Cytokine receptors

Results: 22



#Item
1Cytokine Research Offers a comprehensive menu of cytokines, cytokine receptors and growth factors, across five multi-analyte arrays Cytokine Research

Cytokine Research Offers a comprehensive menu of cytokines, cytokine receptors and growth factors, across five multi-analyte arrays Cytokine Research

Add to Reading List

Source URL: www.lovmand.com

Language: English - Date: 2014-02-17 11:33:05
2Available online http://arthritis-research.com/content/9/S1/S1  Review Biology of RANK, RANKL, and osteoprotegerin Brendan F Boyce and Lianping Xing

Available online http://arthritis-research.com/content/9/S1/S1 Review Biology of RANK, RANKL, and osteoprotegerin Brendan F Boyce and Lianping Xing

Add to Reading List

Source URL: arthritis-research.com

Language: English
3Table 15.1  Myeloproliferative diseases and other myeloid neoplasms associated with point mutation or rearrangement of tyrosine kinase genes.  Disease

Table 15.1  Myeloproliferative diseases and other myeloid neoplasms associated with point mutation or rearrangement of tyrosine kinase genes. Disease

Add to Reading List

Source URL: www.essentialhaematology6.com

Language: English - Date: 2011-02-25 06:19:28
42007 Amgen/ANZBMS Outstanding Abstract Award Recipient

2007 Amgen/ANZBMS Outstanding Abstract Award Recipient

Add to Reading List

Source URL: www.anzbms.org.au

Language: English - Date: 2015-02-22 22:43:33
5SSM[removed]Rev 8- SOMAscan Assay (V3.2) Content

SSM[removed]Rev 8- SOMAscan Assay (V3.2) Content

Add to Reading List

Source URL: www.somalogic.com

Language: English - Date: 2014-06-25 17:02:00
6GM-CSF Granulocyte Macrophage-Colony Stimulating Factor human, recombinant, E. coli Cat. No.

GM-CSF Granulocyte Macrophage-Colony Stimulating Factor human, recombinant, E. coli Cat. No.

Add to Reading List

Source URL: www.jenabioscience.com

Language: English - Date: 2014-04-14 06:02:33
7CRG Licensing Opportunity Ref. CRG-0352 Novel RANKL Antagonists for the treatment of osteoporosis and cancer  In silico design of RANKL inhibitory variants.

CRG Licensing Opportunity Ref. CRG-0352 Novel RANKL Antagonists for the treatment of osteoporosis and cancer  In silico design of RANKL inhibitory variants.

Add to Reading List

Source URL: www.crg.eu

Language: English - Date: 2014-07-01 02:30:53
8Generating chordoma xenografts from the U-CH1 chordoma-derived cell line This work was funded by the Chordoma Foundation: NP by SCAT, LD by Pathological Society, AS by the Egyptian government  *Professor Adrienne M Flana

Generating chordoma xenografts from the U-CH1 chordoma-derived cell line This work was funded by the Chordoma Foundation: NP by SCAT, LD by Pathological Society, AS by the Egyptian government *Professor Adrienne M Flana

Add to Reading List

Source URL: www.chordomafoundation.org

Language: English - Date: 2012-07-22 18:38:49
9Recombinant Advisory Committee Meeting December 4, 2008 • Update on Bone Marrow Transplantation for X-linked Severe Combined Immunodeficiency (X-SCID) at Duke University Medical Center

Recombinant Advisory Committee Meeting December 4, 2008 • Update on Bone Marrow Transplantation for X-linked Severe Combined Immunodeficiency (X-SCID) at Duke University Medical Center

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2014-01-06 11:40:07
10Overview of HLA Identical and Haploidentical BMT in SCID: Duke Experience By: Rebecca H. Buckley, M.D. Duke University Medical Center Durham, NC 27710

Overview of HLA Identical and Haploidentical BMT in SCID: Duke Experience By: Rebecca H. Buckley, M.D. Duke University Medical Center Durham, NC 27710

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2013-12-16 10:03:42